OXURION (EBR:OXUR) | Finanzwire

Basculer en Français

11053	Companies
242360	Keywords
170658	Articles
130453	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 01/13/2025 at 18:00, 1 year 8 months ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converted 4 convertible bonds in Oxurion, leading to a EUR 100,000 capital increase. Oxurion focuses on developing vision-preserving therapeutics for the elderly

Capital Increase Oxurion Atlas Special Opportunities, LLC Innovative Therapeutics Elderly Vision
BRIEF

published on 01/06/2025 at 18:05, 1 year 8 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Transparency Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 01/06/2025 at 18:00, 1 year 8 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities, LLC revealing a stake above 15% threshold due to purchase of voting securities

Transparency Notification Biopharmaceutical Atlas Special Opportunities Ophthalmic Therapies Oxurion NV
BRIEF

published on 01/03/2025 at 18:05, 1 year 8 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Shares Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 01/03/2025 at 18:00, 1 year 8 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
Oxurion NV received a transparency notification under Belgian Transparency legislation from Atlas Special Opportunities, LLC, regarding the sale of voting securities

Transparency Notification Atlas Special Opportunities LLC Oxurion NV Belgian Legislation Retinal Disease Therapy
BRIEF

published on 12/31/2024 at 18:05, 1 year 8 months ago

Oxurion Postpones Strategic Transaction Due to Ongoing Discussions

Report Strategic Transaction Oxurion Leuven Financial Discussions
PRESS RELEASE

published on 12/31/2024 at 18:00, 1 year 8 months ago

Oxurion Announces Postponement of Signing for Strategic Transaction Due to Ongoing Discussions
Oxurion NV announces a short postponement of approximately four weeks for the signing of its strategic transaction due to better than expected financial results of the target. Parties are committed to finalizing the agreement as a key priority

Financial Results Commitment Postponement Strategic Transaction Oxurion NV

Accesswire

Published on 09/22/2026 at 17:00, 3 hours 37 minutes ago

Leggett Dynamics Expands Asia Pacific Headquarters
Published on 09/22/2026 at 16:30, 4 hours 7 minutes ago

Formation Metals Intersects 0.98 g/t Au over 95.6 Metres Starting 7 Metres Below Surface, Including 3.14 g/t Au over the First 10 Metres, Extending the A-Zone Up to 50 Metres North at N2
Published on 09/22/2026 at 15:25, 5 hours 12 minutes ago

Aztec Minerals Announces Closing of Upsized C$6.4 Million Bought Deal Private Placement Including Concurrent Exercise of Underwriter's Option
Published on 09/22/2026 at 15:20, 5 hours 17 minutes ago

MicroVision Introduces Advanced Photonics Technology for Next-Generation AI Data Center Scale-Up Architecture
Published on 09/22/2026 at 15:05, 5 hours 32 minutes ago

Jaguar Health Receives Fee Waivers from FDA

View all ACCESSWIRE

EQS Group

Published on 09/22/2026 at 19:40, 56 minutes ago

EQS-Adhoc: Pyrum Innovations AG: Revision of the Forecast for the Financial Year 2026
Published on 09/22/2026 at 19:00, 1 hour 37 minutes ago

LLB focuses on its "elevate" strategy for growth, excellence and resilience
Published on 09/22/2026 at 18:30, 2 hours 7 minutes ago

Avolta partners with Hawaii’s Department of Transportation to expand airport dining at three airports
Published on 09/22/2026 at 17:45, 2 hours 52 minutes ago

Carvolix submits 510(k) for TAVIPILOT Robot, advancing toward US commercial launch of Its Integrated TAVIPILOT Platform.
Published on 09/22/2026 at 17:40, 2 hours 57 minutes ago

VALBIOTIS SA: Valbiotis announces positive results from the Cardio-Liver clinical study - Commercial launch of ValbiotisPRO® Foie on September 23

Les Echos

Published on 09/22/2026 at 18:10, 2 hours 27 minutes ago

Financial statements - 30 june 2026
Published on 09/22/2026 at 18:00, 2 hours 37 minutes ago

Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 2 hours 52 minutes ago

Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026
Published on 09/21/2026 at 18:19, 1 day 2 hours ago

Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 1 day 2 hours ago

Partnership agreement signed between Manitou Group and HD Construction Equipment

View all LES ECHOS COMFI WIRE